DB
MEDP icon

Dmitry Balyasny’s Medpace MEDP Stock Holding History

Dmitry Balyasny’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,293
Closed -$20.3M – 3320
2026
Q1 		$20.3M Buy
+42,293
New +$21.7M 0.03% 687
2024
Q3 		– Sell
-776
Closed -$320K – 2996
2024
Q2 		$320K Sell
776
-233
-23% -$92.3K ﹤0.01% 2211
2024
Q1 		$408K Sell
1,009
-174
-15% -$61.2K ﹤0.01% 2132
2023
Q4 		$363K Sell
1,183
-21,139
-95% -$5.71M ﹤0.01% 2088
2023
Q3 		$5.4M Buy
+22,322
New +$5.71M 0.01% 1075
2020
Q3 		– Sell
-11,067
Closed -$1.03M – 1469
2020
Q2 		$1.03M Buy
+11,067
New +$942K 0.01% 824
2019
Q2 		– Sell
-15,943
Closed -$940K – 1634
2019
Q1 		$940K Buy
15,943
+1,361
+9% +$81.3K 0.01% 1042
2018
Q4 		$772K Sell
14,582
-1,126
-7% -$61.8K 0.01% 975
2018
Q3 		$941K Buy
+15,708
New +$859K ﹤0.01% 1199
2018
Q2 		– Sell
-14,450
Closed -$504K – 2004
2018
Q1 		$504K Buy
+14,450
New +$528K ﹤0.01% 1441

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Dmitry Balyasny's MEDP Position: Q2 2026 in Review

Dmitry Balyasny sold out of Medpace (MEDP) in Q2 2026, closing a stake of 42,293 shares — an estimated $20.3M sold.

Dmitry Balyasny first reported a position in MEDP in Q1 2018 and held it in 10 quarters. The position peaked at $20.3M in Q1 2026. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Dmitry Balyasny reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 42,293 Medpace shares in Q2 2026, an estimated $20.3M.
  • Dmitry Balyasny first reported a position in Medpace in Q1 2018 and held it in 10 quarters.
  • Dmitry Balyasny's Medpace position peaked at $20.3M in Q1 2026.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.